vancomycin has been researched along with Diabetes Mellitus, Type 1 in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (15.38) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Cao, M; Chen, H; Dong, X; Jia, L; Pan, LL; Ren, Z; Sun, J; Zhang, M | 1 |
Kawanishi, K; Kodama, M; Koike, J; Mitobe, M; Mochizuki, T; Morikawa, S; Nagashima, Y; Nakano, T; Nitta, K; Ohara, M; Sawada, A; Taneda, S | 1 |
Buchanan, R; Draz, N; Gourtsoyannis, Y; Mansell, J | 1 |
Bach, JF; Candon, S; Chatenoud, L; Foray, AP; Marquet, C; Milani, C; Pelletier, B; Perez-Arroyo, A; Valette, F; Ventura, M | 1 |
Hu, Y; Jin, P; Peng, J; Wen, L; Wong, FS; Zhang, X | 1 |
Buschard, K; Hansen, AK; Hansen, CH; Hansen, LH; Krych, L; Nielsen, DS; Sørensen, SJ; Vogensen, FK | 1 |
Barberá Farré, JR; Carranza González, R; Fernández Cenjor, J; Prieto Gómez, E; Tena Gómez, D | 1 |
Chow, JW; Davidson, A; Sanford, E; Zervos, MJ | 1 |
Cosgrove, DM; Gordon, SM; Longworth, DL; Mossad, SB; Serkey, JM | 1 |
Czachor, JS; Garzaro, P; Miller, JR | 1 |
Baranger, B; Brinquin, L; Fangio, P; Petitjeans, F; Rouquette-Vincenti, I; Szymczyszyn, P; Villevieille, T | 1 |
Davis, JL; Flynn, HW; Forster, RK; Koidou-Tsiligianni, A; Miller, D; Pflugfelder, SC | 1 |
1 review(s) available for vancomycin and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Biopsy; Diabetes Mellitus, Type 1; Humans; Male; Nephritis, Interstitial; Vancomycin | 2018 |
12 other study(ies) available for vancomycin and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Butyrate Ameliorates Antibiotic-Driven Type 1 Diabetes in the Female Offspring of Nonobese Diabetic Mice.
Topics: Animals; Anti-Bacterial Agents; Butyrates; Dendritic Cells; Diabetes Mellitus, Type 1; Female; Humans; Interferon-gamma; Interleukin-1beta; Male; Mice; Mice, Inbred NOD; T-Lymphocytes; Vancomycin | 2020 |
Infective endocarditis due to
Topics: Actinobacteria; Adolescent; Anti-Bacterial Agents; Diabetes Mellitus, Type 1; Diagnosis, Differential; Echocardiography, Transesophageal; Endocarditis, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Pulmonary Embolism; Tomography, X-Ray Computed; Tricuspid Valve; Urinary Tract Infections; Vancomycin | 2018 |
Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.
Topics: Animals; Anti-Bacterial Agents; Diabetes Mellitus, Type 1; Female; Gastrointestinal Microbiome; Incidence; Lymphocytes; Male; Mice, Inbred NOD; Mucous Membrane; Spleen; Vancomycin | 2015 |
Different immunological responses to early-life antibiotic exposure affecting autoimmune diabetes development in NOD mice.
Topics: Adoptive Transfer; Animals; Anti-Bacterial Agents; Antigen-Presenting Cells; Bacteria; Diabetes Mellitus, Type 1; Feces; Female; Gastrointestinal Microbiome; Immune System; Incidence; Mice, Inbred NOD; Neomycin; Pregnancy; Prenatal Exposure Delayed Effects; RNA, Ribosomal, 16S; Vancomycin | 2016 |
Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse.
Topics: Algorithms; Analysis of Variance; Animals; Animals, Newborn; Anti-Bacterial Agents; Bacteria; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Flow Cytometry; Incidence; Islets of Langerhans; Male; Mice; Mice, Inbred NOD; Mucins; Vancomycin | 2012 |
[Pneumonia by Corynebacterium pseudodiphteriticum: an infection to consider].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Corynebacterium; Corynebacterium Infections; Diabetes Mellitus, Type 1; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intubation, Intratracheal; Male; Multiple Trauma; Ofloxacin; Pneumonia, Bacterial; Prednisone; Pulmonary Disease, Chronic Obstructive; Sjogren's Syndrome; Smoking; Vancomycin | 2006 |
Clinical Conferences at The Johns Hopkins Hospital: drug-resistant osteomyelitis in a diabetic patient.
Topics: Adult; Cross Infection; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Foot; Foot Diseases; Humans; Neutrophils; Osteomyelitis; Radiography; Staphylococcal Infections; Vancomycin | 1980 |
Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Coronary Artery Bypass; Diabetes Mellitus, Type 1; Drug Hypersensitivity; Endocarditis; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Superinfection; Vancomycin; Virginiamycin; Wound Infection | 1997 |
Coagulase-negative staphylococcal sternal wound infections after open heart operations.
Topics: Anti-Bacterial Agents; Cardiac Surgical Procedures; Case-Control Studies; Coagulase; Diabetes Mellitus, Type 1; Female; Humans; Male; Methicillin Resistance; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; Sternum; Surgical Wound Infection; Vancomycin | 1997 |
Vancomycin and priapism.
Topics: Adult; Bursitis; Diabetes Mellitus, Type 1; Drug Interactions; Humans; Immunosuppressive Agents; Knee Joint; Male; Priapism; Vancomycin | 1998 |
[Obesity, diabetes mellitus, and gas gangrene: a major therapeutic challenge].
Topics: Abscess; Amikacin; Anus Diseases; Buttocks; Candidiasis; Ceftazidime; Colostomy; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 1; Disease Susceptibility; Drug Therapy, Combination; Fasciitis; Female; Gas Gangrene; Humans; Hyperbaric Oxygenation; Hypertension; Metronidazole; Middle Aged; Obesity, Morbid; Postoperative Complications; Shock, Septic; Vancomycin | 2001 |
Coagulase-negative staphylococcal endophthalmitis. Increase in antimicrobial resistance.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Resistance, Microbial; Endophthalmitis; Gentamicins; Humans; Male; Methicillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1988 |